CPhI Istanbul: Pharma's Gateway to High-growth Markets of Eurasia, Central Asia and MENA Regions
AMSTERDAM, June 2, 2014 /PRNewswire/ --
Event will act as regional confluence for 22 countries, with Turkey's domestic demand alone forecast to reach $22.8 billion by 2015
Leading events organiser, UBM Live, announces the opening of CPhI Istanbul 2014, which will take place on June 4th-6th 2014 at the Lutfi Kirdar International Convention and Exhibition Centre in Istanbul.
CPhI Istanbul 2014 provides the first centralised event for regional drug manufacturers to meet with global suppliers of raw materials, machinery, packaging solutions and contract services, as well as attracting visitors from the region looking for suppliers and manufacturing partners to bring cost-competitive pharmaceuticals to their individual markets.
The event will co-locate with P-MEC, InnoPack and ICSE, providing an unrivalled meeting point for bringing together senior pharma professionals and international pharmaceutical suppliers and buyers of pharma raw materials, machinery, packaging solutions and contract services. Collaboratively, the shows are expected to attract around 3,500 visitors, both local and international. The event has formed a strategic partnership with the Pharmaceutical Manufacturers Association of Turkey (IEIS), who are exclusively supporting the event and providing active promotion amongst their members. Additionally, CPhI Istanbul is receiving strategic support from the Pharmaceuticals and Medical Devices Agency.
Highlights of CPhI Istanbul 2014:
- Co-location with P-MEC, InnoPack and ICSE providing services and opportunities through the whole supply chain
- Conference programme, produced by UBM conferences, featuring opinion leaders from government, academia and industry with workshops, round tables and plenary sessions.
- A hosted buyers programme to deliver high-value buyers in growing markets, with key buyers from the MENA region
- Invitation-only welcome reception and networking event
- Potential one-to-one partnering for visitors and exhibitors to provide new leads and business partners
- CPhI press conference: taking place at 10am on 4th June, providing updates and the latest news on CPhI's pharma portfolio. The UBM Live team will be joined by esteemed industry representatives Dr Saim Kerman, President, Pharmaceuticals and Medical Devices Agency and Nezih Barut, Board of Directors Chairman, Pharmaceutical Manufacturers Association of Turkey - IEIS.
CPhI Istanbul 2014 will focus on pharma ingredients, with exhibiting companies covering ingredients, APIs, fine chemicals, excipients, biopharmaceuticals and more. A conference programme will run alongside the event to equip those looking to do business within the region with vital acumen required to break into this dynamic market. Example seminars include 'Turkish Market Access Opportunities And Challenges For Generics Companies', 'Achieving Market Success In The Turkish Biosimilars Market' and 'Evaluating Generics And Biosimilars Opportunities In MENA'. Additionally, key highlights from CPhI's Turkish Pharmaceutical Manufacturing Report will feature at the conference. The report, written jointly with GBR, showcases key findings and provides a wealth of information on the Turkish pharma market and current trends. Copies will be available at the show.
Chris Kilbee, Group Director, CPhI Pharma Portfolio, commented: "CPhI Istanbul will provide an unrivalled opportunity to act as central business hub for the region and will help stimulate growth in what is a dynamic and reforming pharma market. Turkey's pharmaceutical sector is currently ranked seventh in Europe and 16th globally and the next few years are predicted to be a very exciting time for investing. The aim of the event is to bring together local drug manufacturers with regional suppliers to encourage growth and firmly establish the region as a key player within the global pharma industry, with manufacturing at its core.
The UBM Live annual schedule of Pharmaceutical events includes CPhI Istanbul (4-6 June, 2014, at the Lutfi Kirdar Convention and Exhibition Centre - Turkey); CPhI, Hi and Fi, ICSE, P-MEC, BioPh and LabWorld China (26-28 June, 2014 at SNIEC - Shanghai, China); CPhI South America (5-7 August 2014 at Expo Centre Norte - São Paulo, Brazil); CPhI, ICSE Korea (2-3 September, 2014 at the COEX - Seoul, South Korea); CPhI, ICSE, P-MEC and InnoPack Worldwide (7-9 October 2014, Paris Nord Villepinte - France); CPhI and P-MEC India (2-4 December, 2014 at the Bombay Exhibition Centre - Mumbai); CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan (22-24 April, 2015 at the Big Sight Exhibition Centre - Tokyo, Japan). CPhI Russia and IPhEB (27-29 April, 2015 at the VVC, Pavilion Nr 75 - Moscow Russia); CPhI, P-MEC and Innopack South East Asia (26-28 May, 2015 at the Jakarta International Expo - Jakarta, Indonesia)
CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, China, India, Japan, Southeast Asia, Russia, Istanbul and South America co-located with ICSE for contract services, P-MEC for machinery, equipment and technology, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer and supplier directory at CPhI-Online.com and hosts a global community with news and analysis at PharmaEvolution.com.
For more information visit: http://www.cphi.com
About UBM Live
UBM Live connects people and creates opportunities for companies across five continents to develop new business, meet customers, launch new products, promote their brands, and expand their market. Through premier brands such as TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM Live exhibitions, conferences, awards programs, publications, websites, and training and certification programs are an integral part of the marketing plans of companies across more than 20 industry sectors.
SOURCE UBM Live